Latvian Immigration focuses on Life in Latvia: According to a report by the Baltic News Service on September24, Grindex, the largest pharmaceutical company in the Baltic region, has signed a long-term cooperation agreement with the World Health Organization (WHO) for the supply of oxytocin injection. The first batch of medicines will be delivered to North Korea and the Comoros Islands. The company's chairman, Bondaris, stated that this collaboration demonstrates the high quality of the company's products and the professionalism of its employees, which will help the company become a world-class manufacturer of oxytocin.

The report states that since 2008, Grindex has successfully collaborated with the WHO on oxytocin products. Thanks to successful marketing strategies and increased demand, in the first half of 2015, the company's sales of oxytocin products reached 1.3 million euros, a year-on-year increase of 10%.



